Debevoise Advises agilon health in Its IPO

19 April 2021

Debevoise & Plimpton LLP advised agilon health, inc. in its initial public offering of 53.59 million shares of common stock at a price of $23 per share, representing an approximately $1.2 billion offering. The number of shares offered and sold by agilon health included the full exercise of the underwriters’ option to purchase up to an additional 6,990,000 shares of common stock. The IPO closed on April 19, 2021, and the company now trades on the New York Stock Exchange under the ticker symbol “AGL”. For more information, please see the company’s press release.

agilon health partners with primary care physicians to deliver a new and innovative standard of quality and efficiency around senior patient care and experience. Based in Long Beach, California, the company focuses on a Total Care Model powered by its purpose-built platform through a national network of physician partners. The platform helps free physicians from the constraints of the transactional fee-for-service reimbursement model and allows them to practice team-based, coordinated care to serve the individual needs of their senior patients.

The Debevoise team was led by capital markets partners Paul Rodel and Peter Loughran and included associates Benjamin Pedersen, Devon Klein, Charlotte Walkovik, Jason Auman, Kimberly Drexler and Lee Henderson, M&A associate Kim Le, benefits partner Meir Katz and associate David Deutsch and tax partner Peter Furci.